CFX 10Q- 2013 Q3

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 27, 2013
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                     
Commission file number - 001-34045
Colfax Corporation
(Exact name of registrant as specified in its charter)
 
 
 
 
 
Delaware
 
54-1887631
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification Number)
 
 
8170 Maple Lawn Boulevard, Suite 180
Fulton, Maryland
 
20759
(Address of principal executive offices)
 
(Zip Code)
  
(301) 323-9000
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   þ   No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes   þ  No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer þ     Accelerated filer ¨
Non-accelerated filer ¨ (Do not check if a smaller reporting company)     Smaller reporting company ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  þ
As of September 27, 2013, there were 101,903,479 shares of the registrant’s common stock, par value $.001 per share, outstanding.



TABLE OF CONTENTS

 
Page
PART I - FINANCIAL INFORMATION
 
Item 1. Financial Statements
            Condensed Consolidated Statements of Operations
            Condensed Consolidated Statements of Comprehensive Income
            Condensed Consolidated Balance Sheets
            Condensed Consolidated Statement of Equity
            Condensed Consolidated Statements of Cash Flows
            Notes to Condensed Consolidated Financial Statements
                 Note 1. General
                 Note 2. Recently Issued Accounting Pronouncements
                 Note 3. Acquisitions
                 Note 4. Net Income (Loss) Per Share
                 Note 5. Income Taxes
                 Note 6. Equity
                 Note 7. Inventories, Net
                 Note 8. Debt
                 Note 9. Accrued Liabilities
                 Note 10. Net Periodic Benefit Cost - Defined Benefit Plans
                 Note 11. Financial Instruments and Fair Value Measurements
                 Note 12. Commitments and Contingencies
                 Note 13. Segment Information
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
 
 
PART II - OTHER INFORMATION
 
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
 
 
SIGNATURES


1

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements


COLFAX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Dollars in thousands, except per share amounts
(Unaudited)

 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
 
 
 
 
 
 
 
Net sales
$
1,014,570

 
$
954,440

 
$
3,035,831

 
$
2,886,459

Cost of sales
694,276

 
666,453

 
2,086,990

 
2,041,904

Gross profit
320,294

 
287,987

 
948,841

 
844,555

Selling, general and administrative expense
208,132

 
217,143

 
641,835

 
661,191

Charter acquisition-related expense
—

 
—

 
—

 
43,617

Restructuring and other related charges
8,737

 
15,865

 
17,428

 
43,066

Asbestos coverage litigation expense
627

 
3,313

 
2,801

 
8,840

Operating income
102,798

 
51,666

 
286,777

 
87,841

Interest expense
17,536

 
23,557

 
58,879

 
68,280

Income before income taxes
85,262

 
28,109

 
227,898

 
19,561

Provision for income taxes
19,787

 
13,610

 
62,948

 
86,891

Net income (loss)
65,475

 
14,499

 
164,950

 
(67,330
)
Less: income attributable to noncontrolling interest, net of taxes
10,000

 
5,405

 
23,448

 
16,808

Net income (loss) attributable to Colfax Corporation
55,475

 
9,094

 
141,502

 
(84,138
)
Dividends on preferred stock
5,086

 
5,072

 
15,254

 
13,879

Net income (loss) available to Colfax Corporation common shareholders
$
50,389

 
$
4,022

 
$
126,248

 
$
(98,017
)
Net income (loss) per share- basic
$
0.49

 
$
0.04

 
$
1.25

 
$
(1.09
)
Net income (loss) per share- diluted
$
0.48

 
$
0.04

 
$
1.23

 
$
(1.09
)


See Notes to Condensed Consolidated Financial Statements.


2


COLFAX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Dollars in thousands
(Unaudited)

 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
Net income (loss)
$
65,475

 
$
14,499

 
$
164,950

 
$
(67,330
)
Other comprehensive income (loss):
 
 
 
 
 
 
 
Foreign currency translation, net of tax of $(179), $(555), $(803) and $(495)
120,961

 
59,474

 
(52,992
)
 
81,804

Unrealized (loss) gain on hedging activities, net of tax of $808, $538, $165 and $346
(8,001
)
 
1,211

 
(4,576
)
 
(748
)
Amounts reclassified from Accumulated other comprehensive loss:
 
 
 
 
 
 
 
Realized gain on hedging activities, net of tax of $0, $0, $0 and $0
—

 
—

 
—

 
471

Net pension and other postretirement benefit cost, net of tax of $183, $53, $537 and $162
2,583

 
2,074

 
7,740

 
6,232

Other comprehensive income (loss)
115,543

 
62,759

 
(49,828
)
 
87,759

Comprehensive income
181,018

 
77,258

 
115,122

 
20,429

Less: comprehensive income attributable to noncontrolling interest
6,645

 
2,198

 
7,595

 
12,271

Comprehensive income attributable to Colfax Corporation
$
174,373

 
$
75,060

 
$
107,527

 
$
8,158



See Notes to Condensed Consolidated Financial Statements.

3


COLFAX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
Dollars in thousands, except share amounts
(Unaudited)

 
September 27, 2013
 
December 31, 2012
ASSETS
 
 
 
  CURRENT ASSETS:
 
 
 
     Cash and cash equivalents
$
639,255

 
$
482,449

     Trade receivables, less allowance for doubtful accounts of $18,434 and $16,464
974,725

 
873,382

     Inventories, net
453,201

 
493,649

     Other current assets
299,749

 
282,266

  Total current assets
2,366,930

 
2,131,746

  Property, plant and equipment, net
678,173

 
688,570

  Goodwill
2,081,725

 
2,098,836

  Intangible assets, net
741,997

 
779,049

  Other assets
465,063

 
450,086

Total assets
$
6,333,888

 
$
6,148,287

 
 
 
 
LIABILITIES AND EQUITY
 
 
 
  CURRENT LIABILITIES:
 
 
 
     Current portion of long-term debt
$
131,657

 
$
34,799

     Accounts payable
739,225

 
699,626

     Accrued liabilities
450,113

 
447,220

  Total current liabilities
1,320,995

 
1,181,645

  Long-term debt, less current portion
1,389,475

 
1,693,512

  Other liabilities
1,053,388

 
1,116,844

Total liabilities
3,763,858

 
3,992,001

 Equity:
 
 
 
Preferred stock, $0.001 par value; 20,000,000 shares authorized; 13,877,552 issued and outstanding
14

 
14

Common stock, $0.001 par value; 400,000,000 shares authorized; 101,903,479 and 94,067,418 issued and outstanding
102

 
94

  Additional paid-in capital
2,536,527

 
2,197,694

  Accumulated deficit
(12,608
)
 
(138,856
)
  Accumulated other comprehensive loss
(180,950
)
 
(146,594
)
Total Colfax Corporation equity
2,343,085

 
1,912,352

Noncontrolling interest
226,945

 
243,934

Total equity
2,570,030

 
2,156,286

Total liabilities and equity
$
6,333,888

 
$
6,148,287



See Notes to Condensed Consolidated Financial Statements.

4


COLFAX CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF EQUITY
Dollars in thousands, except share amounts and as noted
(Unaudited)

 
Common Stock
Preferred Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Total
 
Shares
$ Amount
Shares
$ Amount
Balance at January 1, 2013
94,067,418

$
94

13,877,552

$
14

$
2,197,694

$
(138,856
)
$
(146,594
)
$
243,934

$
2,156,286

Net income
—

—

—

—

—

141,502

—

23,448

164,950

Distributions to noncontrolling owners
—

—

—

—

—

—

—

(9,097
)
(9,097
)
Acquisition of shares held by noncontrolling interest
—

—

—

—

955

—

(381
)
(15,487
)
(14,913
)
Preferred stock dividend
—

—

—

—

—

(15,254
)
—

—

(15,254
)
Other comprehensive loss
—

—

—

—

—

—

(33,975
)
(15,853
)
(49,828
)
Common stock issuances, net of costs of $12.0 million
7,500,000

8

—

—

319,890

—

—

—

319,898

Common stock-based award activity
247,861

—

—

—

13,111

—

—

—

13,111

Contribution to defined benefit pension plan
88,200

—

—

—

4,877

—

—

—

4,877

Balance at September 27, 2013
101,903,479

$
102

13,877,552

$
14

$
2,536,527

$
(12,608
)
$
(180,950
)
$
226,945

$
2,570,030



See Notes to Condensed Consolidated Financial Statements.

5



COLFAX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Dollars in thousands
(Unaudited)

 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
 
 
 
Cash flows from operating activities:
 
 
 
Net income (loss)
$
164,950

 
$
(67,330
)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
 
 
 
Depreciation, amortization and fixed asset impairment charges
101,648

 
151,278

Stock-based compensation expense
9,788

 
6,429

Deferred income tax provision
4,780

 
40,176

Changes in operating assets and liabilities, net of acquisitions:
 
 
 
Trade receivables, net
(114,731
)
 
(70,304
)
Inventories, net
22,492

 
(27,627
)
Accounts payable
46,841

 
(12,026
)
Changes in other operating assets and liabilities
(48,923
)
 
(11,258
)
Net cash provided by operating activities
186,845

 
9,338

 
 
 
 
Cash flows from investing activities:
 
 
 
Purchases of fixed assets, net
(50,915
)
 
(58,635
)
Acquisitions, net of cash received
(13,722
)
 
(1,691,982
)
Net cash used in investing activities
(64,637
)
 
(1,750,617
)
 
 
 
 
Cash flows from financing activities:
 
 
 
Borrowings under term credit facility
50,861

 
1,731,523

Payments under term credit facility
(274,695
)
 
(521,099
)
Proceeds from borrowings on revolving credit facilities
182,688

 
13,149

Repayments of borrowings on revolving credit facilities
(192,393
)
 
(52,637
)
Payments of deferred loan costs
(2,556
)
 
(9,795
)
Proceeds from issuance of common stock, net
323,289

 
755,113

Proceeds from issuance of preferred stock, net
—

 
332,969

Acquisition of shares held by noncontrolling interest
(14,913
)
 
(29,291
)
Distributions to noncontrolling owners
(9,097
)
 
(8,216
)
Contingent payment on acquisition
(3,500
)
 
—

Payments of dividend on preferred stock
(15,310
)
 
(12,374
)
Net cash provided by financing activities
44,374

 
2,199,342

 
 
 
 
Effect of foreign exchange rates on Cash and cash equivalents
(9,776
)
 
(15,828
)
 
 
 
 
Increase in Cash and cash equivalents
156,806

 
442,235

Cash and cash equivalents, beginning of period
482,449

 
75,108

Cash and cash equivalents, end of period
$
639,255

 
$
517,343



See Notes to Condensed Consolidated Financial Statements.


6
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


1. General
 
Colfax Corporation (the “Company” or “Colfax”) is a diversified global industrial manufacturing and engineering company that provides gas- and fluid-handling and fabrication technology products and services to customers around the world under the Howden, ESAB and Colfax Fluid Handling brand names.

The Condensed Consolidated Financial Statements included in this quarterly report have been prepared by the Company in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements.

The Condensed Consolidated Balance Sheet as of December 31, 2012 is derived from the Company’s audited financial statements. During the three months ended March 29, 2013, adjustments were made retrospectively to provisional amounts recorded as of December 31, 2012, due to the finalization of the valuation of specific tax items related to the acquisition of Charter International plc (“Charter”) by Colfax (the “Charter Acquisition”). See Note 3, “Acquisitions” for additional information regarding these adjustments. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted in accordance with the SEC’s rules and regulations for interim financial statements. The Condensed Consolidated Financial Statements included herein should be read in conjunction with the audited financial statements and related footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012 (the “2012 Form 10-K”), filed with the SEC on February 19, 2013.

The Condensed Consolidated Financial Statements reflect, in the opinion of management, all adjustments, which, except as described above, consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Significant intercompany transactions and accounts are eliminated in consolidation.

The Company makes certain estimates and assumptions in preparing its Condensed Consolidated Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates.

During the three months ended March 29, 2013, Venezuela devalued its currency to an official rate of 6.3 bolivar fuerte (“bolivar”) to the U.S. dollar, representing an approximate 32% devaluation of its currency relative to the U.S. dollar. The Company currently considers Venezuela a highly inflationary currency under GAAP. Therefore, financial statements of the Company’s Venezuelan operation have been remeasured into its parent’s reporting currency, the Colombian peso. Exchange gains and losses from the re-measurement of monetary assets and liabilities are reflected in current earnings. Future impacts to earnings of applying highly inflationary accounting for Venezuela on the Company’s Consolidated Financial Statements will be dependent upon movements in the applicable exchange rates between the bolivar and the Colombian peso and the amount of monetary assets and liabilities included in the Company’s Venezuelan operation’s balance sheet. As of and for the nine months ended September 27, 2013, the Company’s Venezuelan operation represented less than 1% of the Company’s Total assets and Net sales. The bolivar-denominated monetary net asset position, primarily related to Cash and cash equivalents, was $5.7 million in the Condensed Consolidated Balance Sheet as of September 27, 2013. The devaluation of the bolivar and the change to the Colombian peso as the functional currency resulted in a foreign currency transaction loss of $2.9 million recognized in Selling, general and administrative expense for the three months ended March 29, 2013.

The results of operations for the three and nine months ended September 27, 2013 are not necessarily indicative of the results of operations that may be achieved for the full year. Quarterly results are affected by seasonal variations in the Company’s gas- and fluid-handling business. As our gas- and fluid-handling customers seek to fully utilize capital spending budgets before the end of the year, historically our shipments have peaked during the fourth quarter. Also, all of our European operations typically experience a slowdown during the July and August holiday season. General economic conditions may, however, impact future seasonal variations.


7
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

2. Recently Issued Accounting Pronouncements

In March 2013, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2013-05, “Foreign Currency Matters (Topic 830)” (“ASU No. 2013-05”). ASU No. 2013-05 is intended to clarify the parent’s accounting for the cumulative translation adjustment upon the sale or transfer of a group of assets within a consolidated foreign entity. When a parent ceases to have a controlling financial interest in a subsidiary or group of assets within a foreign entity, the parent is required to release any related cumulative translation adjustment into Net income. ASU No. 2013-05 further clarifies that the cumulative translation adjustment should be released into Net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided. ASU No. 2013-05 also clarifies application of this guidance to step acquisitions. ASU No. 2013-05 is effective prospectively for fiscal years beginning after December 15, 2013, with early adoption permitted. The Company will apply the provisions of ASU No. 2013-05 to future sales or transfers of assets of a consolidated foreign entity.

In July 2013, the Financial Accounting Standards Board issued ASU No. 2013-11, “Income Taxes (Topic 740)” (“ASU No. 2013-11”). ASU No. 2013-11 is intended to clarify the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. An unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except in certain circumstances. To the extent a carryforward is not available at the reporting date or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability. ASU No. 2013-11 is effective prospectively to all unrecognized tax benefits that exist at the effective date for fiscal years beginning after December 15, 2013, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU No. 2013-11 on the Company’s Consolidated Balance Sheet.

3. Acquisitions

Charter International plc

On January 13, 2012, Colfax completed the acquisition of Charter for a total purchase price of approximately $2.6 billion, comprised of $1.9 billion of cash consideration and $0.7 billion fair value of common stock on the date of acquisition. Charter is a global industrial manufacturing company focused on welding, cutting and automation and air and gas handling.

The Charter Acquisition was accounted for using the acquisition method of accounting. The measurement period was completed during the three months ended March 29, 2013. During the measurement period, the Company retrospectively adjusted provisional amounts with respect to the Charter Acquisition that were recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. The aggregate adjustments for the three months ended March 29, 2013 of $23.5 million increased the Goodwill balance and relate to the Company’s valuation of specific tax items.

Other

Gas and Fluid Handling

On August 1, 2013, the Company entered into an irrevocable commitment to purchase the global infrastructure and industry division of Fläkt Woods Group (“GII”) for approximately €193 million, including the assumption of debt, subject to certain adjustments. GII has operations around the world and will expand the Company’s product offerings in the industrial fan market. The acquisition of GII is subject to certain regulatory and other approvals and is currently expected to close in the fourth quarter of 2013.

On July 9, 2013, the Company completed the acquisition of the common stock of Clarus Fluid Intelligence (“Clarus”) for $14.3 million, which includes the fair value of an estimated additional contingent cash payment of $3.6 million at the acquisition date. The additional contingent payment will be paid during the year ending December 31, 2016 subject to the achievement of certain performance goals. See Note 11, “Financial Instruments and Fair Value Measurements” for discussion regarding the Company’s liability for contingent payments. Clarus is a domestic supplier of flushing services for marine applications primarily to U.S. government agencies, with primary operations based in Bellingham, Washington.


8
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)

Fabrication Technology

On August 5, 2013, the Company completed a $14.9 million acquisition of common and investment shares of Soldex S.A. (“Soldex”), a publicly traded, less than wholly owned subsidiary in which the Company acquired a controlling interest during the year ended December 31, 2012. This resulted in an increase in the Company’s ownership of the subsidiary from approximately 91% to 99%.

4. Net Income (Loss) Per Share

Net income (loss) per share available to Colfax Corporation common shareholders was computed as follows:
 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
(In thousands, except share data)
Computation of Net income (loss) per share - basic:
 
 
 
 
 
 
 
Net income (loss) available to Colfax Corporation common shareholders
$
50,389

 
$
4,022

 
$
126,248

 
$
(98,017
)
Less: net income attributable to participating securities(1)
—

 
(517
)
 
(3,740
)
 
—

 
$
50,389

 
$
3,505

 
$
122,508

 
$
(98,017
)
Weighted-average shares of Common stock outstanding-basic
101,977,511

 
94,040,440

 
98,185,166

 
90,003,515

Net income (loss) per share - basic
$
0.49

 
$
0.04

 
$
1.25

 
$
(1.09
)
Computation of Net income (loss) per share - diluted:
 
 
 
 
 
 
 
Net income (loss) available to Colfax Corporation common shareholders
$
50,389

 
$
4,022

 
$
126,248

 
$
(98,017
)
Less: net income attributable to participating securities(1)(2)
—

 
(517
)
 
(3,740
)
 
—

Add: dividends on preferred stock(2)
5,086

 
—

 
—

 
—

 
$
55,475

 
$
3,505

 
$
122,508

 
$
(98,017
)
Weighted-average shares of Common stock outstanding-basic
101,977,511

 
94,040,440

 
98,185,166

 
90,003,515

Net effect of potentially dilutive securities - stock options and restricted stock units
1,233,867

 
751,488

 
1,096,504

 
—

Net effect of potentially dilutive securities - convertible preferred stock(2)
12,173,291

 
—

 
—

 
—

Weighted-average shares of Common stock outstanding-diluted
115,384,669

 
94,791,928

 
99,281,670

 
90,003,515

Net income (loss) per share - diluted
$
0.48

 
$
0.04

 
$
1.23

 
$
(1.09
)
 
(1) Net income (loss) per share was calculated consistent with the two-class method in accordance with GAAP through April 23, 2013, as further discussed below.
(2) For periods subsequent to April 23, 2013, Net income per share - dilutive was calculated in accordance with the if-converted method, as further discussed below. However, for the nine months ended September 27, 2013, the calculation under this method was anti-dilutive.

On April 23, 2013, the Company and BDT CF Acquisition Vehicle, LLC amended the Certificate of Designations of Series A Perpetual Convertible Preferred Stock of Colfax Corporation to eliminate the right of the Series A Convertible Preferred Stock to share proportionately in any dividends or distributions made in respect of the Company’s Common stock. BDT CF Acquisition Vehicle, LLC is the sole holder of all issued and outstanding shares of the Company’s Series A Convertible Preferred Stock. For periods prior to April 23, 2013, Net income available to Colfax Corporation common shareholders was allocated to participating securities, while any losses for those periods were not allocated to the participating securities. Effective April 23, 2013, the Company’s Series A Convertible Preferred Stock is no longer considered a participating security. For periods subsequent to April 23, 2013, the Company’s Net income per share - dilutive is computed using the “if-converted” method. Under the “if-converted” method, Net income per share - dilutive is calculated under the assumption that the shares of Series A Convertible Preferred Stock have been converted into shares of Common stock as of the beginning of the respective period. For the nine months ended September 27, 2013, the weighted-average computation of the dilutive effect of potentially issuable shares of Common stock excludes 12.2 million shares assuming that the shares of Series A Convertible Preferred Stock have been converted, as inclusion of such shares would be anti-dilutive.


9
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)

The weighted-average computation of the dilutive effect of potentially issuable shares of Common stock under the treasury stock method for the three months ended September 27, 2013 and September 28, 2012 excludes approximately 0.6 million and 1.4 million outstanding stock-based compensation awards, respectively, as their inclusion would be anti-dilutive. The weighted-average computation of the dilutive effect of potentially issuable shares of Common stock under the treasury stock method for the nine months ended September 27, 2013 and September 28, 2012 excludes approximately 0.7 million and 2.8 million outstanding stock-based compensation awards, respectively, as their inclusion would be anti-dilutive.

5. Income Taxes

During the three months ended September 27, 2013, Income before income taxes was $85.3 million and the Provision for income taxes was $19.8 million. The effective tax rate of 23.2% for the three months ended September 27, 2013 differs from the U.S. federal statutory rate primarily due to international tax rates, which are lower than the U.S. tax rate, and a discrete credit to income tax expense of $5.1 million from a reduction to deferred tax balances in certain territories associated with the enactment of lower corporate tax rates, which were offset in part by losses in certain jurisdictions where a tax benefit is not expected to be recognized in 2013.

During the nine months ended September 27, 2013, Income before income taxes was $227.9 million and the Provision for income taxes was $62.9 million. The effective tax rate of 27.6% for the nine months ended September 27, 2013 differs from the U.S. federal statutory rate primarily due to international tax rates, which are lower than the U.S. tax rate, a discrete credit to income tax expense of $5.1 million from a reduction to deferred tax balances in certain territories associated with the enactment of lower corporate tax rates and the resolution of a liability for unrecognized tax benefits, which resulted in a gain of $2.3 million, all of which were offset in part by other discrete tax items and losses in certain jurisdictions where a tax benefit is not expected to be recognized in 2013.

During the three months ended September 28, 2012, Income before income taxes was $28.1 million and the Provision for income taxes was $13.6 million. The Provision for income taxes for the three months ended September 28, 2012 was significantly impacted by increased corporate overhead and Interest expense related to the combined organization reflected in the Condensed Consolidated Statement of Operations, which were incurred in jurisdictions where no tax benefit can be recognized. These items were partially offset by a discrete credit to income tax expense of $2.9 million from a reduction to deferred tax balances in the United Kingdom associated with the enactment of lower corporate tax rates.

During the nine months ended September 28, 2012, Income before income taxes was $19.6 million and the Provision for income taxes was $86.9 million, which was impacted by two significant items. Upon completion of the Charter Acquisition, certain deferred tax assets existing at that date were reassessed in light of the impact of the acquired businesses on expected future income or loss by country and future tax planning, including the impact of the post-acquisition capital structure. This assessment resulted in an increase in the Company’s valuation allowance to provide full valuation allowances against U.S. deferred tax assets. The increased valuation allowances resulted in an increase to the Provision for income taxes for the nine months ended September 28, 2012 of $50.3 million. In addition, $43.6 million of Charter acquisition-related expense and increased corporate overhead and Interest expense reflected in the Condensed Consolidated Statement of Operations are either non-deductible or were incurred in jurisdictions where no tax benefit can be recognized. These two items are the principal cause of tax provision rather than the tax benefit which would result from the application of the U.S. federal statutory rate to the reported net loss.

6. Equity

Common Stock

On May 13, 2013, the Company sold 7,500,000 shares of newly issued Colfax Common stock to underwriters for public resale pursuant to a shelf registration statement for an aggregate purchase price of $331.9 million. In conjunction with this issuance, the Company recognized $12.0 million in equity issuance costs which were recorded as a reduction to Additional paid-in capital during the nine months ended September 27, 2013.

On September 12, 2013, the Company contributed 88,200 shares of newly issued Colfax Common stock to its U.S. defined benefit pension plan.


10
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)

Accumulated Other Comprehensive Loss

The following table presents the changes in the balances of each component of Accumulated other comprehensive loss including current period reclassifications out of Accumulated other comprehensive loss for the nine months ended September 27, 2013. All amounts are net of tax and noncontrolling interest.

 
Accumulated Other Comprehensive Loss Components
 
Net Unrecognized Pension And Other Post-Retirement Benefit Cost
 
Foreign Currency Translation Adjustment
 
Unrealized (Loss) Gain On Hedging Activities
 
Total
 
(In thousands)
 
 
 
 
 
 
 
 
Beginning balance
$
(247,332
)
 
$
104,718

 
$
(3,980
)
 
$
(146,594
)
Acquisition of shares held by noncontrolling interest
—

 
(381
)
 
—

 
(381
)
Other comprehensive loss before reclassifications:
 
 
 
 
 
 
 
Foreign currency translation adjustment
—

 
(42,706
)
 
—

 
(42,706
)
Gain on long-term intra-entity foreign currency transactions
—

 
5,546

 
—

 
5,546

Loss on net investment hedges
—

 
—

 
(6,299
)
 
(6,299
)
Unrealized gain on cash flow hedges
—

 
—

 
1,744

 
1,744

Other comprehensive loss before reclassifications
—

 
(37,160
)
 
(4,555
)
 
(41,715
)
Amounts reclassified from Accumulated other comprehensive loss
7,740

 
—

 
—

 
7,740

Net current period other comprehensive income (loss)
7,740

 
(37,160
)
 
(4,555
)
 
(33,975
)
Ending balance
$
(239,592
)
 
$
67,177

 
$
(8,535
)
 
$
(180,950
)

The effect on Net income (loss) of amounts reclassified out of each component of Accumulated other comprehensive loss for the three and nine months ended September 27, 2013 is as follows:
 
Three Months Ended September 27, 2013
 
Nine Months Ended September 27, 2013
 
Amounts Reclassified From Accumulated Other Comprehensive Loss
 
Tax Benefit
 
Total
 
Amounts Reclassified From Accumulated Other Comprehensive Loss
 
Tax Benefit
 
Total
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
 
Pension and other post-retirement benefit cost:
 
 
 
 
 
 
 
 
 
 
 
Amortization of net loss (1)
$
2,704

 
$
(183
)
 
$
2,521

 
$
8,091

 
$
(537
)
 
$
7,554

Amortization of prior service cost(1)
62

 
—

 
62

 
186

 
—

 
186

 
$
2,766

 
$
(183
)
 
$
2,583

 
$
8,277

 
$
(537
)
 
$
7,740

 
(1) Included in the computation of net periodic benefit cost. See Note 10, “Net Periodic Benefit Cost - Defined Benefit Plans” for additional details.

During the nine months ended September 27, 2013, Noncontrolling interest decreased by $15.9 million as a result of Other comprehensive loss, primarily due to currency translation adjustment.


11
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)

7. Inventories, Net

Inventories, net consisted of the following:
 
September 27, 2013
 
December 31, 2012
 
(In thousands)
Raw materials
$
134,311

 
$
154,771

Work in process
96,772

 
99,459

Finished goods
238,054

 
263,211

 
469,137

 
517,441

Less: customer progress billings
(5,520
)
 
(14,571
)
Less: allowance for excess, slow-moving and obsolete inventory
(10,416
)
 
(9,221
)
Inventories, net
$
453,201

 
$
493,649


8. Debt

Long-term debt consisted of the following:
 
September 27, 2013
 
December 31, 2012
 
(In thousands)
Term loans
$
1,484,704

 
$
1,682,177

Revolving credit facilities and other
36,428

 
46,134

Total Debt
1,521,132

 
1,728,311

Less: current portion
(131,657
)
 
(34,799
)
Long-term debt
$
1,389,475

 
$
1,693,512


On February 22, 2013, the Company entered into the Second Amendment to its credit agreement (the “Deutsche Bank Credit Agreement”), by and among the Company, Colfax UK Holdings Ltd, the other subsidiaries of the Company party thereto, the lenders party thereto and Deutsche Bank AG New York Branch, as administrative agent (the “Second Amendment”). Pursuant to the Second Amendment, the Company amended its credit agreement to, among other things, (i) reallocate the borrowing capacities of the tranches of loans as follows: a $408.7 million term A-1 facility, a $380 million term A-2 facility, a €157.6 million term A-3 facility, a €105.3 million term A-4 facility, a $400 million term B facility and two revolving credit subfacilities which total $500 million in commitments, (ii) provide for an interest rate margin on the term A-1 facility, the term A-2 facility and the revolving credit subfacilities ranging from 0.75% to 1.50% per annum for base rate loans and 1.75% to 2.50% per annum for Eurocurrency rate loans, in each case, determined by the Company’s leverage ratio, (iii) provide for an interest rate margin on the term A-3 facility and the term A-4 facility ranging from 1.50% to 2.25% per annum for base rate loans and 2.50% to 3.25% per annum for Eurocurrency rate loans, in each case, determined by the Company’s leverage ratio and (iv) provide for an interest rate margin on the term B facility of 1.50% per annum for base rate loans and 2.50% per annum for Eurocurrency rate loans. In conjunction with the Second Amendment, the Company recorded a charge to Interest expense in the Condensed Consolidated Statement of Operations for the nine months ended September 27, 2013 of $2.6 million to write-off certain deferred financing fees and original issue discount and expensed approximately $0.5 million of costs incurred in connection with the refinancing. The Company had an original issue discount of $40.3 million and deferred financing fees of $15.7 million included in its Condensed Consolidated Balance Sheet as of September 27, 2013, which will be accreted to Interest expense primarily using the effective interest method, over the life of the Deutsche Bank Credit Agreement. As of September 27, 2013, the weighted-average interest rate of borrowings under the amended Deutsche Bank Credit Agreement was 2.61%, excluding accretion of original issue discount, and there was $499.9 million available on the revolving credit subfacilities, including $199.9 million available on a letter of credit subfacility.

The Company is also party to additional letter of credit facilities with total capacity of $628.1 million, of which $362.2 million was outstanding as of September 27, 2013.

As of September 27, 2013, the Company is in compliance with the covenants under the Deutsche Bank Credit Agreement.


12
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)

9. Accrued Liabilities

Accrued liabilities in the Condensed Consolidated Balance Sheets consisted of the following:

 
September 27, 2013
 
December 31, 2012
 
(In thousands)
Accrued payroll
$
108,640

 
$
99,583

Advance payment from customers
58,050

 
61,431

Accrued taxes
71,793

 
34,165

Accrued asbestos-related liability
59,354

 
58,501

Warranty liability - current portion
34,808

 
35,678

Accrued restructuring liability - current portion
12,162

 
25,406

Accrued third-party commissions
12,695

 
12,320

Other
92,611

 
120,136

Accrued liabilities
$
450,113

 
$
447,220


Warranty Liability
 
The activity in the Company’s warranty liability consisted of the following:
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
(In thousands)
Warranty liability, beginning of period
$
40,437

 
$
2,987

Accrued warranty expense
16,633

 
9,728

Changes in estimates related to pre-existing warranties
(693
)
 
15

Cost of warranty service work performed
(14,862
)
 
(18,200
)
Acquisitions
—

 
47,341

Foreign exchange translation effect
(476
)
 
(1,300
)
Warranty liability, end of period
$
41,039

 
$
40,571


Accrued Restructuring Liability

The Company’s restructuring programs include a series of restructuring actions at its fluid-handling operations beginning in 2009 and ongoing initiatives as a result of the Charter Acquisition as well as efforts to reduce the structural costs and rationalize the corporate overhead of the combined businesses.


13
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)

A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Condensed Consolidated Balance Sheets is as follows:

 
Nine Months Ended September 27, 2013
 
Balance at Beginning of Period
 
Provisions
 
Payments
 
Foreign Currency Translation
 
Balance at End of Period(3)
 
(In thousands)
Restructuring and other related charges:
 
 
 
 
 
 
 
 
Gas and Fluid Handling:
 
 
 
 
 
 
 
 
 
Termination benefits(1)
$
3,060

 
$
4,014

 
$
(5,426
)
 
$
(43
)
 
$
1,605

Facility closure costs(2)
1,177

 
529

 
(878
)
 
20

 
848

Other related charges
—

 
201

 
(177
)
 
15

 
39

 
4,237

 
4,744

 
(6,481
)
 
(8
)
 
2,492

Fabrication Technology:
 
 
 
 
 
 
 
 
 
Termination benefits(1)
14,637

 
10,661

 
(18,213
)
 
275

 
7,360

Facility closure costs(2)
6,925

 
1,096

 
(5,622
)
 
(6
)
 
2,393

Other related charges
33

 
927

 
(914
)
 
(70
)
 
(24
)
 
21,595

 
12,684

 
(24,749
)
 
199

 
9,729

Corporate and Other:
 
 
 
 
 
 
 
 
 
Facility closure costs(2)
1,522

 
—

 
(197
)
 
(17
)
 
1,308

 
1,522

 
—

 
(197
)
 
(17
)
 
1,308

 
$
27,354

 
$
17,428

 
$
(31,427
)
 
$
174

 
$
13,529

    
 
(1) Includes severance and other termination benefits, including outplacement services. The Company recognizes the cost of involuntary
termination benefits at the communication date or ratably over any remaining expected future service period. Voluntary termination benefits
are recognized as a liability and an expense when employees accept the offer and the amount can be reasonably estimated.
(2) Includes the cost of relocating associates, relocating equipment and lease termination expense in connection with the closure of facilities.
(3) As of September 27, 2013, $12.2 million and $1.3 million of the Company’s restructuring liability was included in Accrued liabilities and
Other liabilities, respectively.

The Company expects to incur Restructuring and other related charges of approximately $20 million during the remainder of 2013 related to these restructuring activities.


14
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)


10. Net Periodic Benefit Cost - Defined Benefit Plans

The following table sets forth the components of net periodic benefit cost of the defined benefit pension plans and the Company’s other post-retirement employee benefit plans:
 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
(In thousands)
Pension Benefits-U.S. Plans:
 
 
 
 
 
 
 
     Service cost
$
—

 
$
—

 
$
—

 
$
—

     Interest cost
4,352

 
4,699

 
13,126

 
14,044

     Expected return on plan assets
(6,192
)
 
(6,050
)
 
(18,611
)
 
(18,093
)
     Amortization
1,964

 
1,800

 
5,891

 
5,400

Net periodic benefit cost
$
124

 
$
449

 
$
406

 
$
1,351

 
 
 
 
 
 
 
 
 Pension Benefits-Non U.S. Plans:
 
 
 
 
 
 
 
     Service cost
$
598

 
$
828

 
$
2,420

 
$
2,388

     Interest cost
11,089

 
11,638

 
33,293

 
34,573

     Expected return on plan assets
(8,295
)
 
(8,143
)
 
(24,785
)
 
(24,467
)
     Amortization
626

 
184

 
1,857

 
564

Net periodic benefit cost
$
4,018

 
$
4,507

 
$
12,785

 
$
13,058

 
 
 
 
 
 
 
 
Other Post-Retirement Benefits:
 
 
 
 
 
 
 
     Service cost
$
32

 
$
50

 
$
167

 
$
152

     Interest cost
229

 
310

 
686

 
949

     Amortization
176

 
232

 
529

 
698

Net periodic benefit cost
$
437

 
$
592

 
$
1,382

 
$
1,799


11. Financial Instruments and Fair Value Measurements

The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair value of the Company’s debt of $1.5 billion and $1.7 billion as of September 27, 2013 and December 31, 2012, respectively, was based on current interest rates for similar types of borrowings and is in Level Two of the fair value hierarchy. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future.


15
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)

A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows:
 
September 27, 2013
 
Level
One
 
Level
Two
 
Level
Three
 
Total
 
(In thousands)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
299,700

 
$
—

 
$
—

 
$
299,700

 Foreign currency contracts related to sales - designated as hedges
—

 
9,049

 
—

 
9,049

 Foreign currency contracts related to sales - not designated as hedges
—

 
3,084

 
—

 
3,084

 Foreign currency contracts related to purchases - designated as hedges
—

 
399

 
—

 
399

 Foreign currency contracts related to purchases - not designated as hedges
—

 
480

 
—

 
480

 Deferred compensation plans
—

 
2,887

 
—

 
2,887

 
$
299,700

 
$
15,899

 
$
—

 
$
315,599

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 Foreign currency contracts related to sales - designated as hedges
$
—

 
$
1,308

 
$
—

 
$
1,308

 Foreign currency contracts related to sales - not designated as hedges
—

 
809

 
—

 
809

 Foreign currency contracts related to purchases - designated as hedges
—

 
799

 
—

 
799

 Foreign currency contracts related to purchases - not designated as hedges
—

 
713

 
—

 
713

 Deferred compensation plans
—

 
2,887

 
—

 
2,887

 Liability for contingent payments
—

 
—

 
7,034

 
7,034

 
$
—

 
$
6,516

 
$
7,034

 
$
13,550


 
December 31, 2012
 
Level
One
 
Level
Two
 
Level
Three
 
Total
 
(In thousands)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
133,878

 
$
—

 
$
—

 
$
133,878

 Foreign currency contracts related to sales - designated as hedges
—

 
6,832

 
—

 
6,832

 Foreign currency contracts related to sales - not designated as hedges
—

 
2,249

 
—

 
2,249

 Foreign currency contracts related to purchases - designated as hedges
—

 
213

 
—

 
213

 Foreign currency contracts related to purchases - not designated as hedges
—

 
1,077

 
—

 
1,077

 Deferred compensation plans
—

 
2,542

 
—

 
2,542

 
$
133,878

 
$
12,913

 
$
—

 
$
146,791

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 Foreign currency contracts related to sales - designated as hedges
$
—

 
$
1,024

 
$
—

 
$
1,024

 Foreign currency contracts related to sales - not designated as hedges
—

 
1,693

 
—

 
1,693

 Foreign currency contracts related to purchases - designated as hedges
—

 
896

 
—

 
896

 Foreign currency contracts related to purchases - not designated as hedges
—

 
1,062

 
—

 
1,062

 Deferred compensation plans
—

 
2,542

 
—

 
2,542

 Liability for contingent payments
—

 
—

 
6,517

 
6,517

 
$
—

 
$
7,217

 
$
6,517

 
$
13,734


There were no transfers in or out of Level One, Two or Three during the nine months ended September 27, 2013.


16
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)

Foreign Currency Contracts. As of September 27, 2013 and December 31, 2012, the Company had foreign currency contracts with the following notional values:
 
September 27, 2013
 
December 31, 2012
 
(In thousands)
Foreign currency contracts sold - not designated as hedges
$
221,268

 
$
301,185

Foreign currency contracts sold - designated as hedges
187,997

 
238,537

Foreign currency contracts purchased - not designated as hedges
235,665

 
121,741

Foreign currency contracts purchased - designated as hedges
48,283

 
37,065

Total foreign currency derivatives
$
693,213

 
$
698,528


The Company recognized the following in its Condensed Consolidated Financial Statements related to its derivative instruments:
 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
(In thousands)
Contracts Designated as Hedges:
 
 
 
  Interest Rate Swap:
 
 
 
     Realized loss
$
—

 
$
—

 
$
—

 
$
(471
)
  Foreign Currency Contracts - related to customer sales contracts:
 
 
 
 
 
 
 
     Unrealized gain
3,248

 
3,070

 
2,658

 
822

     Realized gain (loss)
3,355

 
1,757

 
(116
)
 
1,077

  Foreign Currency Contracts - related to supplier purchase contracts:
 
 
 
 
 
 
 
     Unrealized gain (loss)
908

 
497

 
(145
)
 
(352
)
     Realized (loss) gain
(1,425
)
 
(579
)
 
76

 
(344
)
  Unrealized loss on net investment hedges
(13,562
)
 
(2,760
)
 
(6,299
)
 
(2,764
)
Contracts Not Designated in a Hedge Relationship:
 
 
 
 
 
 
 
  Foreign Currency Contracts - acquisition-related:
 
 
 
 
 
 
 
     Realized loss
—

 
—

 
—

 
(7,177
)
  Foreign Currency Contracts - related to customer sales contracts:
 
 
 
 
 
 
 
     Unrealized gain
2,765

 
1,774

 
1,495

 
154

     Realized gain
1,940

 
879

 
1,162

 
1,789

  Foreign Currency Contracts - related to supplier purchases contracts:
 
 
 
 
 
 
 
      Unrealized gain (loss)
63

 
(223
)
 
513

 
3

      Realized (loss) gain
(1,121
)
 
1

 
579

 
(33
)

Liability for Contingent Payments

The Company’s liability for contingent payments represents the fair value of estimated additional cash payments related to its acquisitions of COT-Puritech, Inc. in December of 2011 and Clarus in July 2013, which are subject to the achievement of certain performance goals, and are included in Other liabilities in the Condensed Consolidated Balance Sheets. The fair value of the liability for contingent payments represents the present value of probability weighted expected cash flows based upon the Company’s internal model and projections and is included in Level Three of the fair value hierarchy. Accretion is recognized in Interest expense in the Condensed Consolidated Statements of Operations and realized or unrealized gains or losses are recognized in Selling, general and administrative expense in the Condensed Consolidated Statements of Operations.


17
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)

A summary of activity in the Company’s liability for contingent payments during the nine months ended September 27, 2013 is as follows:
 
 (In thousands)
Balance at January 1, 2013
$
6,517

Additions for Clarus acquisition
3,592

Interest accretion
425

Cash payment
(3,500
)
Balance at September 27, 2013
$
7,034


12. Commitments and Contingencies

For further description of the Company’s litigation and contingencies, reference is made to Note 16, “Commitments and Contingencies” in the Notes to Consolidated Financial Statements in our 2012 Form 10-K.

Asbestos and Other Product Liability Contingencies

Claims activity since December 31 related to asbestos claims is as follows(1):
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
(Number of claims)
Claims unresolved, beginning of period
23,523

 
25,281

Claims filed(2)
3,298

 
3,281

Claims resolved(3)
(3,875
)
 
(4,703
)
Claims unresolved, end of period
22,946

 
23,859

 
(1) Excludes claims filed by one legal firm that have been “administratively dismissed.”
(2) Claims filed include all asbestos claims for which notification has been received or a file has been opened.
(3) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based
upon agreements or understandings in place with counsel for the claimants.

The Company’s Condensed Consolidated Balance Sheets included the following amounts related to asbestos-related litigation:
 
September 27, 2013
 
December 31, 2012
 
(In thousands)
Current asbestos insurance asset(1)

$
32,893

 
$
35,566

Current asbestos insurance receivable(1)

42,031

 
36,778

Long-term asbestos insurance asset(2)
307,445

 
315,363

Long-term asbestos insurance receivable(2)

20,934

 
7,063

Accrued asbestos liability(3)

59,354

 
58,501

Long-term asbestos liability(4)

367,493

 
375,493

 
(1) Included in Other current assets in the Condensed Consolidated Balance Sheets.
(2) Included in Other assets in the Condensed Consolidated Balance Sheets.
(3) Represents current reserves for probable and reasonably estimable asbestos-related liability cost that the Company believes the subsidiaries
will pay through the next 15 years, overpayments by certain insurers and unpaid legal costs related to defending themselves against
asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Condensed
Consolidated Balance Sheets.
(4) Included in Other liabilities in the Condensed Consolidated Balance Sheets.

Due to a statistically significant increase in mesothelioma and lung cancer claims and higher settlement values per claim that have occurred and are expected to continue to occur in certain jurisdictions, partially offset by lower claims and lower settlement values per claim in other jurisdictions, the Company recorded a $0.6 million pre-tax charge during the three and nine months ended September 27, 2013, which was included in Selling, general and administrative expense in the Condensed Consolidated Statements

18
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)

of Operations. The pre-tax charge was comprised of an increase in asbestos-related liabilities of $10.8 million partially offset by an increase in expected insurance recoveries of $10.2 million.

Management’s analyses are based on currently known facts and a number of assumptions. However, projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded which could materially affect the Company’s financial condition, results of operations or cash flow.

The Company is also involved in various other pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings are expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings and the litigation and claims described in the preceding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate reserves to cover potential liabilities. Any costs that management estimates may be paid related to these proceedings or claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adverse to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company.

13. Segment Information

The Company conducts its operations through three operating segments: gas handling, fluid handling and fabrication technology. The gas-handling and fluid-handling operating segments are aggregated into a single reportable segment. A description of the Company’s reportable segments is as follows:

▪
Gas & Fluid Handling - a global supplier of a broad range of gas- and fluid-handling products, including pumps, fluid-handling systems and controls, specialty valves, heavy-duty centrifugal and axial fans, rotary heat exchangers and gas compressors, which serves customers in the power generation, oil, gas and petrochemical, mining, marine (including defense) and general industrial and other end markets; and

▪
Fabrication Technology - a global supplier of welding equipment and consumables, cutting equipment and consumables and automated welding and cutting systems.
 
Certain amounts not allocated to the two reportable segments and intersegment eliminations are reported under the heading “Corporate and other.” The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and segment operating income, which represents Operating income before Restructuring and other related charges.


19
COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

The Company’s segment results were as follows:
 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
(In thousands)
Net sales:
 
 
 
     Gas and fluid handling
$
511,360

 
$
464,873

 
$
1,453,228

 
$
1,386,699

     Fabrication technology
503,210

 
489,567

 
1,582,603

 
1,499,760

 
$
1,014,570

 
$
954,440

 
$
3,035,831

 
$
2,886,459

Segment operating income (loss)(1):
 
 
 
 
 
 
 
     Gas and fluid handling
$
67,413

 
$
33,925

 
$
179,341

 
$
98,846

     Fabrication technology
57,583

 
43,855

 
161,478

 
106,262

     Corporate and other
(13,461
)
 
(10,249
)
 
(36,614
)
 
(74,201
)
 
$
111,535

 
$
67,531

 
$
304,205

 
$
130,907


(1) The following is a reconciliation of Income before income taxes to segment operating income:
 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
(In thousands)
Income before income taxes
$
85,262

 
$
28,109

 
$
227,898

 
$
19,561

Interest expense
17,536

 
23,557

 
58,879

 
68,280

Restructuring and other related charges
8,737

 
15,865

 
17,428

 
43,066

Segment operating income
$
111,535

 
$
67,531

 
$
304,205

 
$
130,907


The detail of the Company’s Net sales by product type is as follows:

 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
(In thousands)
Gas handling
$
349,485

 
$
311,919

 
$
977,016

 
$
898,081

Fluid handling
161,875

 
152,954

 
476,212

 
488,618

Welding and cutting
503,210

 
489,567

 
1,582,603

 
1,499,760

Total Net sales
$
1,014,570

 
$
954,440

 
$
3,035,831

 
$
2,886,459



20

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of the financial condition and results of operations of Colfax Corporation (“Colfax,” “the Company,” “we,” “our,” and “us”) should be read in conjunction with the Condensed Consolidated Financial Statements and related footnotes included in Part I. Item 1.“Financial Statements” of this Quarterly Report on Form 10-Q for the quarterly period ended September 27, 2013 (this “Form 10-Q”) and the Consolidated Financial Statements and related footnotes included in Part II. Item 8. “Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year ended December 31, 2012 (the “2012 Form 10-K”) filed with the Securities and Exchange Commission (the “SEC”) on February 19, 2013.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Some of the statements contained in this Form 10-Q that are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date this Form 10-Q is filed with the SEC. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including statements regarding: projections of revenue, profit margins, expenses, tax provisions and tax rates, earnings or losses from operations, impact of foreign exchange rates, cash flows, pension and benefit obligations and funding requirements, synergies or other financial items; plans, strategies and objectives of management for future operations including statements relating to potential acquisitions, compensation plans or purchase commitments; developments, performance or industry or market rankings relating to products or services; future economic conditions or performance; the outcome of outstanding claims or legal proceedings including asbestos-related liabilities and insurance coverage litigation; potential gains and recoveries of costs; assumptions underlying any of the foregoing; and any other statements that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Forward-looking statements may be characterized by terminology such as “believe,” “anticipate,” “should,” “would,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy,” “targets,” “aims,” “seeks,” “sees,” and similar expressions. These statements are based on assumptions and assessments made by our management in light of their experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. These forward-looking statements are subject to a number of risks and uncertainties, including but not limited to the following:

•
changes in the general economy, as well as the cyclical nature of the markets we serve;

•
our ability to identify, finance, acquire and successfully integrate attractive acquisition targets;

•
our ability to successfully integrate Charter International plc (“Charter”);

•
our exposure to unanticipated liabilities resulting from acquisitions;

•
our ability and the ability of our customers to access required capital at a reasonable cost;

•
our ability to accurately estimate the cost of or realize savings from our restructuring programs;

•
the amount of and our ability to estimate our asbestos-related liabilities;

•
the solvency of our insurers and the likelihood of their payment for asbestos-related costs;

•
material disruptions at any of our manufacturing facilities;

•
noncompliance with various laws and regulations associated with our international operations, including anti-bribery laws, export control regulations and United States (“U.S.”) sanctions and embargoes on certain foreign countries;

•
risks associated with our international operations;

•
risks associated with the representation of our employees by trade unions and work councils;


21

•
our exposure to product liability claims;

•
failure to maintain and protect our intellectual property rights;

•
the loss of key members of our leadership team;

•
restrictions in our credit agreement with Deutsche Bank Securities Inc., HSBC Securities (USA) Inc. and certain other lender parties named therein (the “Deutsche Bank Credit Agreement”) that may limit our flexibility in operating our business;

•
impairment in the value of intangible assets;

•
the funding requirements or obligations of our defined benefit pension plans and other post-retirement benefit plans;

•
significant movements in foreign currency exchange rates;

•
availability and cost of raw materials, parts and components used in our products;

•
service interruptions, data corruption, cyber-based attacks or network security breaches affecting our information technology infrastructure;

•
risks arising from changes in technology;

•
the competitive environment in our industry;

•
changes in our tax rates or exposure to additional income tax liabilities;

•
our ability to manage and grow our business and execution of our business and growth strategies;

•
the level of capital investment and expenditures by our customers in our strategic markets;

•
our financial performance; and

•
other risks and factors, listed in Item 1A. “Risk Factors” in Part I of our 2012 Form 10-K.

Any such forward-looking statements are not guarantees of future performance and actual results, developments and business decisions may differ materially from those envisaged by such forward-looking statements. These forward-looking statements speak only as of the date this Form 10-Q is filed with the SEC. We do not assume any obligation and do not intend to update any forward-looking statement except as required by law. See Part I. Item 1A. “Risk Factors” in our 2012 Form 10-K for a further discussion regarding some of the reasons that actual results may be materially different from those that we anticipate.

Overview

We report our operations through the following reportable segments:

•
Gas & Fluid Handling - a global supplier of a broad range of gas- and fluid-handling products, including pumps, fluid-handling systems and controls, specialty valves, heavy-duty centrifugal and axial fans, rotary heat exchangers and gas compressors, which serves customers in the power generation, oil, gas and petrochemical, mining, marine (including defense) and general industrial and other end markets; and
•
Fabrication Technology - a global supplier of welding equipment and consumables, cutting equipment and consumables and automated welding and cutting systems.

Certain amounts not allocated to the two reportable segments and intersegment eliminations are reported under the heading “Corporate and other.”


22

Colfax has a global geographic footprint, with production facilities in Europe, North America, South America, Asia, Australia and Africa. Through our reportable segments, we serve a global customer base across multiple markets through a combination of direct sales and third-party distribution channels. Our customer base is highly diversified and includes commercial, industrial and government customers.

We employ a comprehensive set of tools that we refer to as the Colfax Business System (“CBS”). CBS, modeled on the Danaher Business System, is our business management system. It is a repeatable, teachable process that we use to create superior value for our customers, shareholders and associates. Rooted in our core values, it is our culture. CBS provides the tools and techniques to ensure that we are continuously improving our ability to meet or exceed customer requirements on a consistent basis.

Results of Operations

The following discussion of Results of Operations addresses the comparison of the periods presented. The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and segment operating income (loss), which represents Operating income before Restructuring and other related charges.

Items Affecting Comparability of Reported Results

The comparability of our operating results for the third quarter and nine months ended September 27, 2013 to the comparable 2012 period is affected by the following additional significant items:

Strategic Acquisitions

We complement our organic growth with strategic acquisitions. Acquisitions can significantly affect our reported results and can complicate period to period comparisons of results. As a consequence, we report the change in our Net sales between periods both from existing and acquired businesses. Orders and order backlog are presented only for the gas- and fluid-handling segment, where this information is relevant. The change in Net sales due to acquisitions represents the change in sales due to the following acquisitions:

On January 13, 2012, Colfax completed the acquisition of Charter (the “Charter Acquisition”) for a total purchase price of approximately $2.6 billion. Charter is a global industrial manufacturing company focused on welding, cutting and automation and air and gas handling. The impact of the additional 12 days of operations is included in the change in Net sales due to acquisitions.

Gas and Fluid Handling

On September 13, 2012, Colfax completed the acquisition of the Co-Vent Group Inc. (“Co-Vent”) for $34.6 million. Co-Vent specializes in the custom design, manufacture, and testing of industrial fans, with its primary operations based in Quebec, Canada. As a result of this acquisition, Colfax has expanded its product offerings in the industrial fan market.

On July 9, 2013, Colfax completed the acquisition of the common stock of Clarus Fluid Intelligence (“Clarus”) for $14.3 million, which includes the fair value of an estimated additional contingent cash payment of $3.6 million at the acquisition date. The additional contingent payment will be paid during the year ending December 31, 2016 subject to the achievement of certain performance goals. Clarus is a domestic supplier of flushing services for marine applications primarily to U.S. government agencies, with primary operations based in Bellingham, Washington.

Fabrication Technology

In May 2012, Colfax acquired the remaining 83.7% of CJSC Sibes (“Sibes”) not already owned by its ESAB business for approximately $8.5 million, including the assumption of debt. Sibes is a leading supplier of welding electrodes to customers in Eastern Russia and strengthens ESAB’s position in the attractive Russian welding consumables market, particularly in the energy and natural resources end markets.

On October 31, 2012, Colfax completed the acquisition of approximately 91% of the outstanding common and investment shares of Soldex for approximately $187.2 million. Soldex is organized under the laws of Peru and complements our existing fabrication technology segment by supplying welding products from its plants in Colombia and Peru. On August 5, 2013, we completed a $14.9 million acquisition of common and investment shares of Soldex resulting in an increase in our ownership of the subsidiary from approximately 91% to 99%.


23


Foreign Currency Fluctuations

A significant portion of our Net sales, approximately 81% and 80% for the third quarter and nine months ended September 27, 2013, respectively, is derived from operations outside the U.S., with the majority of those sales denominated in currencies other than the U.S. dollar. Because much of our manufacturing and employee costs are outside the U.S., a significant portion of our costs are also denominated in currencies other than the U.S. dollar. Changes in foreign exchange rates can impact our results of operations and are quantified when significant to our discussion.

Seasonality

As our gas- and fluid-handling customers seek to fully utilize capital spending budgets before the end of the year, historically our shipments have peaked during the fourth quarter. Also, all of our European operations typically experience a slowdown during the July and August holiday season. General economic conditions may, however, impact future seasonal variations.

Sales, Orders and Backlog

Our consolidated Net sales increased from Net sales of $954.4 million in the third quarter of 2012 to $1,014.6 million in the third quarter of 2013. Our Net sales increased from Net sales of $2,886.5 million in the nine months ended September 28, 2012 to $3,035.8 million in the nine months ended September 27, 2013. The following tables present components of our consolidated Net sales and, for our gas- and fluid-handling segment, order and backlog growth:
 
Net Sales
 
Orders(1)
 
$
 
%
 
$
 
%
 
(In millions)
For the three months ended September 28, 2012
$
954.4

 
 
 
$
443.8

 
 
Components of Change:
 
 
 
 
 
 
 
Existing businesses(2)
29.1

 
3.0
 %
 
72.6

 
16.4
%
Acquisitions(3)
37.6

 
3.9
 %
 
6.7

 
1.5
%
Foreign currency translation(4)
(6.5
)
 
(0.6
)%
 
10.2

 
2.3
%
 
60.2

 
6.3
 %
 
89.5

 
20.2
%
For the three months ended September 27, 2013
$
1,014.6

 
 
 
$
533.3

 
 

 
Net Sales
 
Orders(1)
 
Backlog at Period End
 
$
 
%
 
$
 
%
 
$
 
%
 
(In millions)
As of and for the nine months ended September 28, 2012
$
2,886.5

 
 
 
$
1,475.7

 
 
 
$
1,382.4

 
 
Components of Change:
 
 
 
 
 
 
 
 
 
 
 
Existing businesses(2)
2.4

 
0.1
 %
 
(2.5
)
 
(0.2
)%
 
44.7

 
3.2
 %
Acquisitions(3)
180.2

 
6.2
 %
 
46.2

 
3.1
 %
 
21.4

 
1.6
 %
Foreign currency translation(4)
(33.3
)
 
(1.1
)%
 
(5.8
)
 
(0.3
)%
 
(1.6
)
 
(0.1
)%
 
149.3

 
5.2
 %
 
37.9

 
2.6
 %
 
64.5

 
4.7
 %
As of and for the nine months ended September 27, 2013
$
3,035.8

 
 
 
$
1,513.6

 
 
 
$
1,446.9

 
 
 
(1) Represents contracts for products or services, net of cancellations for the period, for our gas- and fluid-handling operating segment.
(2) Excludes the impact of foreign exchange rate fluctuations and acquisitions, thus providing a measure of growth due to factors such as price,
product mix and volume.
(3) Represents the incremental sales, orders and order backlog as a result of our acquisitions of Charter, Soldex, Co-Vent and Clarus. The impact related to the Charter Acquisition represents 12 days of activity for ESAB and Howden as the acquisition closed on January 13, 2012.
(4) Represents the difference between prior year sales and orders valued at the actual prior year foreign exchange rates and prior year sales and orders valued at current year foreign exchange rates.


24

The increase in Net sales from existing businesses during the third quarter of 2013 compared to the third quarter of 2012 was attributable to an increase of $34.9 million in our gas- and fluid-handling segment, partially offset by a decrease of $5.8 million in our fabrication technology segment. Orders, net of cancellations, from existing businesses for our gas- and fluid-handling segment increased during the third quarter of 2013 in comparison to the third quarter of 2012 due to increases in all end markets except marine.

The increase in Net sales from existing businesses during the nine months ended September 27, 2013 compared to the nine months ended September 28, 2012 was attributable to an increase of $45.8 million in our gas- and fluid-handling segment, offset by a decrease of $43.4 million in our fabrication technology segment. Orders, net of cancellations, from existing businesses for our gas- and fluid-handling segment decreased during the nine months ended September 27, 2013 in comparison to the nine months ended September 28, 2012 due to decreases in the oil, gas and petrochemical, mining and general industrial and other end markets, offset by increases in the power generation and marine end markets.

Business Segments

As discussed further above, the Company reports results in two reportable segments: gas and fluid handling and fabrication technology. The following table summarizes Net sales by reportable segment for each of the following periods:
 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
(In millions)
Gas and Fluid Handling
$
511.4

 
$
464.9

 
$
1,453.2

 
$
1,386.7

Fabrication Technology
503.2

 
489.5

 
1,582.6

 
1,499.8

Total Net sales
$
1,014.6

 
$
954.4

 
$
3,035.8

 
$
2,886.5


Gas and Fluid Handling

We design, manufacture, install and maintain gas- and fluid-handling products for use in a wide range of markets, including power generation, oil, gas and petrochemical, mining, marine (including defense) and general industrial and other. Our gas-handling products are principally marketed under the Howden brand name. Howden’s primary products are heavy-duty fans, rotary heat exchangers and compressors. The fans and heat exchangers are used in coal-fired and other types of power stations, both in combustion and emissions control applications, underground mines, steel sintering plants and other industrial facilities that require movement of large volumes of air in harsh applications. Howden’s compressors are mainly used in the oil, gas and petrochemical end market. Our fluid-handling products are marketed by Colfax Fluid Handling under a portfolio of brands including Allweiler, Baric, Fairmount Automation, Houttuin, Imo, LSC, COT-Puritech, Portland Valve, Tushaco, Warren and Zenith. Colfax Fluid Handling is a supplier of a broad range of fluid-handling products, including pumps, fluid-handling systems and controls, and specialty valves.

The following table summarizes selected financial data for our gas- and fluid-handling segment:
 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
(Dollars in millions)
Net sales
$
511.4

 
$
464.9

 
$
1,453.2

 
$
1,386.7

Gross profit
153.4

 
139.0

 
439.4

 
410.7

Gross profit margin
30.0
%
 
29.9
%
 
30.2
%
 
29.6
%
Restructuring and other related charges
$
3.2

 
$
1.6

 
$
4.7

 
$
5.4

Selling, general and administrative expense
85.4

 
101.7

 
257.3

 
303.0

Selling, general and administrative expense as a percentage of Net sales
16.7
%
 
21.9
%
 
17.7
%
 
21.9
%
Segment operating income
$
67.4

 
$
33.9

 
$
179.3

 
$
98.8

Segment operating income margin
13.2
%
 
7.3
%
 
12.3
%
 
7.1
%

The $34.9 million Net sales increase due to existing businesses during the third quarter of 2013 in comparison to the third quarter of 2012, as discussed and defined under “Sales, Orders and Backlog” above, was primarily due to growth in the power generation, marine and general industrial and other end markets, partially offset by declines in the oil, gas and petrochemical and

25

mining end markets. Additionally, Net sales increased by $6.7 million due to acquisition-related growth, and by $4.9 million due to changes in foreign exchange rates. Gross profit increased in the third quarter of 2013 reflecting the positive impact of higher volumes and strong cost control activities. Selling, general and administrative expense for the third quarter of 2013 decreased compared to the third quarter of 2012 primarily due to a decrease of $14.5 million in acquisition-related amortization expense.

The $45.8 million Net sales increase due to existing businesses during the nine months ended September 27, 2013 in comparison to the nine months ended September 28, 2012, as discussed and defined under “Sales, Orders and Backlog” above, was primarily due to growth in the power generation, marine and general industrial and other end markets, partially offset by declines in the oil, gas and petrochemical and mining end markets. Additionally, Net sales increased by $26.4 million due to acquisition-related growth, including 12 additional days of activity in Howden, which was partially offset by a decrease of $5.7 million due to changes in foreign exchange rates. Gross profit increased during the nine months ended September 27, 2013 reflecting the positive impact of higher volumes and strong cost control activities. Selling, general and administrative expense for the nine months ended September 27, 2013 decreased compared to the nine months ended September 28, 2012 primarily due to a decrease of $41.1 million in acquisition-related amortization expense. Additionally, $4.5 million of acquisition-related amortization expense was reflected in Gross profit for the nine months ended September 28, 2012.

Fabrication Technology

We formulate, develop, manufacture and supply consumable products and equipment for use in the cutting and joining of steels, aluminum and other metals and metal alloys. Our fabrication technology products are principally marketed under the ESAB brand name, which we believe is a leading international welding company with roots dating back to the invention of the welding electrode. ESAB’s comprehensive range of welding consumables includes electrodes, cored and solid wires and fluxes. ESAB’s fabrication technology equipment ranges from portable units to large custom systems. Products are sold into a wide range of end markets, including wind power, shipbuilding, pipelines, mobile/off-highway equipment and mining.

The following table summarizes selected financial data for our fabrication technology segment:
 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
(Dollars in millions)
Net sales
$
503.2

 
$
489.6

 
$
1,582.6

 
$
1,499.8

Gross profit
166.9

 
148.9

 
509.4

 
433.8

Gross profit margin
33.2
%
 
30.4
%
 
32.2
%
 
28.9
%
Restructuring and other related charges
$
5.5

 
$
12.5

 
$
12.7

 
$
31.6

Selling, general and administrative expense
109.2

 
105.1

 
347.9

 
327.6

Selling, general and administrative expense as a percentage of Net sales
21.7
%
 
21.5
%
 
22.0
%
 
21.8
%
Segment operating income
$
57.6

 
$
43.9

 
$
161.5

 
$
106.3

Segment operating income margin
11.4
%
 
9.0
%
 
10.2
%
 
7.1
%

The $13.7 million Net sales increase during the third quarter of 2013 compared to the third quarter of 2012 was primarily the result of acquisition-related growth of $30.9 million. The $5.8 million Net sales decline due to existing businesses during the third quarter of 2013 in comparison to the third quarter of 2012, as discussed and defined under “Sales, Orders and Backlog” above, was primarily the result of decreases in consumable volumes in Russia and North America. In the third quarter of 2013, Gross profit and gross profit margin were favorably impacted by the fixed costs eliminated by several manufacturing site closings in late 2012 and the higher gross profit margins at Soldex. The decrease in Restructuring and other related charges in the third quarter of 2013 compared to the third quarter of 2012 was primarily related to the completion of several substantial cost reduction programs. The increase in Selling, general and administrative expense during the third quarter of 2013 compared to the third quarter of 2012 was primarily related to a $6.2 million increase resulting from the acquisition of Soldex.

The $82.8 million Net sales increase during the nine months ended September 27, 2013 compared to the nine months ended September 28, 2012 was primarily the result of acquisition-related growth of $153.8 million, including 12 additional days of activity in ESAB. The $43.4 million Net sales decline due to existing businesses during the nine months ended September 27, 2013 in comparison to the nine months ended September 28, 2012, as discussed and defined under “Sales, Orders and Backlog” above, was primarily the result of decreases in consumable volumes in Europe, Asia and North America. Gross profit and gross profit margin for the nine months ended September 28, 2012 were impacted by acquisition-related inventory step-up expense of $17.0 million. In the nine months ended September 27, 2013, Gross profit and gross profit margin were favorably impacted by

26

the fixed costs eliminated by several manufacturing site closings in late 2012 and the higher gross profit margins at Soldex. Additionally, Selling, general and administrative expense increased by $23.5 million due to the acquisition of Soldex. This amount includes the impact of the devaluation of the Venezuelan bolivar fuerte, which resulted in a foreign currency transaction loss of $2.9 million recognized in Selling, general and administrative expense for the nine months ended September 27, 2013. Selling, general and administrative expense was also impacted by the inclusion of an additional 12 days of operations in 2013 compared to the nine months ended September 28, 2012. See Note 1, “General” in the accompanying Notes to Condensed Consolidated Financial Statements included in this Form 10-Q for additional discussion regarding the devaluation of the Venezuelan bolivar fuerte.

Gross Profit - Total Company
 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
(Dollars in millions)
Gross profit
$
320.3

 
$
288.0

 
$
948.8

 
$
844.6

Gross profit margin
31.6
%
 
30.2
%
 
31.3
%
 
29.3
%

The $32.3 million increase in Gross profit during the third quarter of 2013 in comparison to the third quarter of 2012 was attributable to increases of $14.3 million in our gas- and fluid-handling segment and $18.0 million in our fabrication technology segment. Gross profit and gross profit margin increased during the third quarter of 2013 primarily due to the impact of our cost reduction efforts. Changes in foreign exchange rates during the third quarter of 2013 had a $6.8 million negative impact on Gross profit in comparison to the third quarter of 2012.

The $104.2 million increase in Gross profit during the nine months ended September 27, 2013 in comparison to the nine months ended September 28, 2012 was attributable to increases of $28.7 million in our gas- and fluid-handling segment and $75.6 million in our fabrication technology segment. Gross profit and gross profit margin increased during the nine months ended September 27, 2013 due to $21.5 million of acquisition-related inventory step-up expense incurred in the nine months ended September 28, 2012. The improvement in gross profit margin during the period was also due to the impact of our cost reduction efforts. Changes in foreign exchange rates during the nine months ended September 27, 2013 had a $15.0 million negative impact on Gross profit in comparison to the nine months ended September 28, 2012.

Operating Expenses - Total Company
 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
(Dollars in millions)
Selling, general and administrative expense
$
208.1

 
$
217.1

 
$
641.8

 
$
661.2

Selling, general and administrative expense as a percentage of Net sales
20.5
%
 
22.7
%
 
21.1
%
 
22.9
%
Charter acquisition-related expense
—

 
—

 
—

 
43.6

Restructuring and other related charges
8.7

 
15.9

 
17.4

 
43.1

Asbestos coverage litigation expense
0.6

 
3.3

 
2.8

 
8.8


Selling, general and administrative expense decreased $9.0 million during the third quarter of 2013 in comparison to the third quarter of 2012 primarily due to a decrease in acquisition-related amortization expense of $14.5 million, partially offset by the increase in expenses resulting from the acquisition of Soldex. Restructuring and other related charges decreased in the third quarter of 2013 in comparison to the third quarter of 2012 primarily as a result of the completion of several substantial cost reduction programs in the fabrication technology segment. Additionally, Asbestos coverage litigation expense decreased in the third quarter of 2013 because in the third quarter of 2012 significant costs were incurred for the preparation of our appeals submissions related to a case decided by the trial court during 2011 and for depositions and preparation for a trial related to a subsidiary’s coverage which was conducted in the fourth quarter of 2012.

Selling, general and administrative expense decreased $19.4 million during the nine months ended September 27, 2013 in comparison to the nine months ended September 28, 2012, primarily due to a decrease in acquisition-related amortization expense of $41.1 million, partially offset by the increase in expenses resulting from the additional 12 days of operations related to the entities acquired as part of the Charter Acquisition and the acquisition of Soldex. During the nine months ended September 28, 2012, we incurred $43.6 million of advisory, legal, valuation and other professional service fees and realized losses on acquisition-

27

related foreign exchange derivatives in connection with the Charter Acquisition. Restructuring and other related charges decreased in the nine months ended September 27, 2013 in comparison to the nine months ended September 28, 2012 primarily as a result of the completion of several substantial cost reduction programs in the fabrication technology segment. Additionally, Asbestos coverage litigation expense decreased in the nine months ended September 27, 2013 because in the nine months ended September 28, 2012 significant costs were incurred for the preparation of our appeals submissions related to a case decided by the trial court during 2011 and for depositions and preparation for a trial related to a subsidiary’s coverage which was conducted in the fourth quarter of 2012.

Interest Expense - Total Company
 
Three Months Ended
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
September 27, 2013
 
September 28, 2012
 
(In millions)
Interest expense
$
17.5

 
$
23.6

 
$
58.9

 
$
68.3


The decrease in Interest expense during the third quarter and nine months ended September 27, 2013 in comparison to the comparable 2012 period was primarily attributable to the favorable impact of lower borrowing rates and lower outstanding borrowing levels associated with the Second Amendment to the Deutsche Bank Credit Agreement, as defined and further discussed under “—Liquidity and Capital Resources—Borrowing Arrangements” below. Additionally, the decrease in Interest expense for the nine months ended September 27, 2013 was partially offset by $3.1 million of charges related to the Second Amendment to the Deutsche Bank Credit Agreement.

Provision for Income Taxes - Total Company

The effective income tax rate for the third quarter of 2013 was 23.2% compared to an effective tax rate of 48.4% during the third quarter of 2012. Our effective income tax rate for the third quarter of 2013 was lower than the U.S. federal statutory tax rate primarily due to foreign earnings where international tax rates are lower than the U.S. tax rate and a discrete credit to income tax expense of $5.1 million from a reduction to deferred tax balances in certain territories associated with the enactment of lower corporate tax rates, which were offset in part by losses in certain jurisdictions where a tax benefit is not expected to be recognized in 2013. Our effective income tax rate for the third quarter of 2012 was significantly impacted by increased corporate overhead and Interest expense related to the combined organization, which was incurred in jurisdictions where no tax benefit can be recognized. These items were partially offset by a discrete credit to income tax expense of $2.9 million from a reduction in the U.K. associated with the enactment of lower corporate tax rates.

The effective tax rate for the nine months ended September 27, 2013 was 27.6%, which was lower than the U.S. federal statutory tax rate primarily due to foreign earnings where international tax rates are lower than the U.S. tax rate, a discrete credit to income tax expense of $5.1 million from a reduction to deferred tax balances in certain territories associated with the enactment of lower corporate tax rates and the resolution of a liability for unrecognized tax benefits, which resulted in a gain of $2.3 million, all of which were offset in part by other discrete tax items and losses in certain jurisdictions where a tax benefit is not expected to be recognized in 2013.

During the nine months ended September 28, 2012, Loss before income taxes was $19.6 million and the Provision for income taxes was $86.9 million. The Provision for income taxes was impacted by two significant items. Upon completion of the Charter Acquisition, certain deferred tax assets existing at that date were reassessed in light of the impact of the acquired businesses on expected future income or loss by country and future tax planning, including the impact of the post-acquisition capital structure. This assessment resulted in an increase in our valuation allowance to provide full valuation allowances against U.S. deferred tax assets. The increased valuation allowances resulted in a non-cash increase to the Provision for income taxes for the nine months ended September 28, 2012 of $50.3 million. In addition, $43.6 million of Charter acquisition-related expense reflected in the Condensed Consolidated Statement of Operations is either non-deductible or was incurred in jurisdictions where no tax benefit can be recognized. These two items are the principal cause of the Provision for income taxes being significantly higher than the tax provision which would result from the application of the U.S. federal statutory rate to the reported Net loss.


28

Liquidity and Capital Resources

Overview

Historically, we have financed our capital and working capital requirements through a combination of cash flows from operating activities, borrowings under our bank credit facilities and the issuances of equity. We expect that our primary ongoing requirements for cash will be for working capital, funding of acquisitions, capital expenditures, asbestos-related cash outflows and funding of our pension plans. If additional funds are needed for strategic acquisitions or other corporate purposes, we believe we could raise additional funds in the form of debt or equity.

Equity Capital

On May 13, 2013, the Company sold 7,500,000 shares of newly issued Colfax Common stock to underwriters for public resale pursuant to a shelf registration statement for an aggregate purchase price of $331.9 million. In conjunction with this issuance, the Company recognized $12.0 million in equity issuance costs which were recorded as a reduction to Additional paid-in capital during the nine months ended September 27, 2013.

On September 12, 2013, the Company contributed 88,200 shares of newly issued Colfax Common stock to its U.S. defined benefit pension plan.

Borrowing Arrangements

On February 22, 2013, Colfax entered into the Second Amendment to the Deutsche Bank Credit Agreement, as amended, by and among the Company, Colfax UK Holdings Ltd, the other subsidiaries of the Company party thereto, the lenders party thereto and Deutsche Bank AG New York Branch, as administrative agent (the “Second Amendment”). Pursuant to the Second Amendment, the Company amended its credit agreement to, among other things, (i) reallocate the borrowing capacities of the tranches of loans as follows: a $408.7 million term A-1 facility, a $380 million term A-2 facility, a €157.6 million term A-3 facility, a €105.3 million term A-4 facility, a $400 million term B facility and two revolving credit subfacilities which total $500 million in commitments, (ii) provide for an interest rate margin on the term A-1 facility, the term A-2 facility and the revolving credit subfacilities ranging from 0.75% to 1.50% per annum for base rate loans and 1.75% to 2.50% per annum for Eurocurrency rate loans, in each case, determined by the Company’s leverage ratio, (iii) provide for an interest rate margin on the term A-3 facility and the term A-4 facility ranging from 1.50% to 2.25% per annum for base rate loans and 2.50% to 3.25% per annum for Eurocurrency rate loans, in each case, determined by the Company’s leverage ratio and (iv) provide for an interest rate margin on the term B facility of 1.50% per annum for base rate loans and 2.50% per annum for Eurocurrency rate loans. Other amendments and modifications are more fully set forth in the full text of the Second Amendment. In conjunction with the modification to our debt in the Second Amendment, the Company recorded a charge to Interest expense of $2.6 million to write-off certain deferred financing fees and original issue discount and expensed approximately $0.5 million of costs incurred in connection with the refinancing. The Company had an original issue discount of $40.3 million and deferred financing fees of $15.7 million included in its Condensed Consolidated Balance Sheet as of September 27, 2013, which will be accreted to Interest expense primarily using the effective interest method, over the life of the amended Deutsche Bank Credit Agreement. As of September 27, 2013, the weighted-average interest rate of borrowings under the amended Deutsche Bank Credit Agreement was 2.61%, excluding accretion of original issue discount, and there was $499.9 million available on the revolving credit subfacilities, including $199.9 million available on a letter of credit subfacility.

The Company is also party to additional letter of credit facilities with total capacity of $628.1 million, of which $362.2 million was outstanding as of September 27, 2013.

In connection with the Second Amendment, the Company has pledged substantially all of its domestic subsidiaries’ assets and 65% of the shares of certain first tier international subsidiaries as collateral against borrowings to its U.S. companies. In addition, subsidiaries in certain foreign jurisdictions have guaranteed the Company’s obligations on borrowings of one of its European subsidiaries, as well as pledged substantially all of their assets for such borrowings to this European subsidiary under the Deutsche Bank Credit Agreement. The Deutsche Bank Credit Agreement contains customary covenants limiting the Company’s ability to, among other things, pay dividends, incur debt or liens, redeem or repurchase equity, enter into transactions with affiliates, make investments, merge or consolidate with others or dispose of assets. In addition, the Deutsche Bank Credit Agreement contains financial covenants requiring the Company to maintain a total leverage ratio, as defined therein, of not more than 4.95 to 1.0 and a minimum interest coverage ratio, as defined therein, of 2.25 to 1.0, measured at the end of each quarter, through the year ended December 31, 2013. The minimum interest coverage ratio increases by 25 basis points each year until it reaches 3.0 to 1.0 for the year ended December 31, 2016. The maximum total leverage ratio decreases to 4.75 to 1.0 for the year ended December 31, 2014

29

and decreases by 25 basis points for the two subsequent fiscal years until it reaches 4.25 to 1.0 for the year ended December 31, 2016. The Deutsche Bank Credit Agreement contains various events of default, including failure to comply with such financial covenants, and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the term loans and the revolving credit subfacilities and foreclose on the collateral. There were no material changes to the covenants in the Second Amendment to the Deutsche Bank Credit Agreement. The Company is in compliance with all such covenants as of September 27, 2013. We believe that our sources of liquidity, including the Deutsche Bank Credit Agreement, are adequate to fund our operations for the next twelve months.

Cash Flows

As of September 27, 2013, we had $639.3 million of Cash and cash equivalents, an increase of $156.9 million from $482.4 million as of December 31, 2012. The following table summarizes the change in Cash and cash equivalents during the periods indicated:
 
Nine Months Ended
 
September 27, 2013
 
September 28, 2012
 
(In millions)
Net cash provided by operating activities
$
186.8

 
$
9.3

Purchases of fixed assets, net
(50.9
)
 
(58.6
)
Acquisitions, net of cash received
(13.7
)
 
(1,692.0
)
Net cash used in investing activities
(64.6
)
 
(1,750.6
)
(Repayments) proceeds from borrowings, net
(233.5
)
 
1,170.9

Proceeds from issuance of common stock, net
323.3

 
755.1

Proceeds from issuance of preferred stock, net
—

 
333.0

Acquisition of shares held by noncontrolling interest
(14.9
)
 
(29.3
)
Other uses, net
(30.5
)
 
(30.4
)
Net cash provided by financing activities
44.4

 
2,199.3

Effect of exchange rates on Cash and cash equivalents
(9.7
)
 
(15.8
)
Increase in Cash and cash equivalents
$
156.9

 
$
442.2


Cash flows from operating activities can fluctuate significantly from period to period due to changes in working capital and the timing of payments for items such as pension funding and asbestos-related costs. Changes in significant operating cash flow items are discussed below.

•
Net cash received or paid for asbestos-related costs, net of insurance proceeds, including the disposition of claims, defense costs and legal expenses related to litigation against our insurers, creates variability in our operating cash flows. We had net cash outflows of $27.1 million and $34.3 million during the nine months ended September 27, 2013 and September 28, 2012, respectively.
•
Funding requirements of our defined benefit plans, including pension plans and other post-retirement benefit plans, can vary significantly from period to period due to changes in the fair value of plan assets and actuarial assumptions. For the nine months ended September 27, 2013 and September 28, 2012, cash contributions for defined benefit plans were $37.0 million and $50.3 million, respectively. The nine months ended September 28, 2012 included $18.9 million of supplemental contributions to pension plans in the United Kingdom as a result of the financing of the Charter Acquisition.
•
During the nine months ended September 27, 2013 and September 28, 2012, cash payments of $31.4 million and $32.4 million, respectively, were made related to our restructuring initiatives. Additionally, during the nine months ended September 28, 2012 cash payments of approximately $45 million were made for advisory, legal, valuation and other professional service fees related to the Charter Acquisition.
•
Changes in net working capital also affected the operating cash flows for the periods presented. We define working capital as Trade receivables, net and Inventories, net reduced by Accounts payable. During the nine months ended September 27, 2013, net working capital increased, primarily due to an increase in receivables partially offset by an increase in payables and a decrease in inventory levels, which decreased our cash flows from operating activities. These fluctuations

30

are in line with typical seasonal trends. During the nine months ended September 28, 2012, net working capital increased, primarily due to an increase in inventory and receivable levels, which reduced our cash flows from operating activities.
There were significant investing activities associated with the Charter Acquisition. The cash cost of the Charter Acquisition, which was completed in the nine months ended September 28, 2012, was approximately $1.7 billion, net of cash acquired.

Cash flows from financing activities for the nine months ended September 27, 2013 were impacted by the Second Amendment to the Deutsche Bank Credit Agreement further discussed above under “—Borrowing Arrangements” and the May 2013 sale of newly issued Common stock further discussed above under “—Equity Capital.” The sale of our Common stock in May 2013 generated $319.9 million cash inflows from financing activities.

Cash flows from financing activities for the nine months ended September 28, 2012 were significantly impacted by the Charter Acquisition. We raised $805.0 million of cash from sales of our equity securities to BDT CF Acquisition Vehicle, LLC, Steven and Mitchell Rales, and Markel Corporation (“Markel”). Mitchell P. Rales, Chairman of Colfax’s Board of Directors, and his brother Steven M. Rales, were each beneficial owners of 20.9% of Colfax’s Common stock at the time of the sale. Thomas S. Gayner, a member of Colfax’s Board of Directors, is President and Chief Investment Officer of Markel. We borrowed approximately $1.8 billion of term loans, $68 million of which was repaid in the nine months ended September 28, 2012. The additional payment of borrowings under term loans of $455 million primarily represent the repayment of borrowings under our Bank of America Credit Agreement, in conjunction with the financing of the Charter Acquisition. Additionally, financing activities for the nine months ended September 28, 2012 included $293 million raised in a primary offering of our Common stock settled in March 2012.

Cash flows from financing activities were also impacted by acquisitions of shares of less than wholly owned subsidiaries. During the nine months ended September 27, 2013 cash flows from financing activities included a $14.9 million acquisition of common and investment shares of Soldex resulting in an increase in our ownership of the subsidiary from approximately 91% to 99%. During the nine months ended September 28, 2012 cash flows from financing activities included a $29.4 million acquisition of shares in ESAB India Limited, a publicly traded, less than wholly owned subsidiary in which the Company acquired a controlling interest in the Charter Acquisition. This acquisition of shares was pursuant to a statutorily mandated tender offer triggered as a result of the Charter Acquisition.

Our Cash and cash equivalents as of September 27, 2013 includes $343.0 million held in jurisdictions outside the U.S., which may be subject to tax penalties if repatriated into the U.S. and other restrictions.

Contractual Obligations

On August 1, 2013, we entered into an irrevocable commitment to purchase the global infrastructure and industry division of Fläkt Woods Group (“GII”) for approximately €193 million, including the assumption of debt, subject to certain adjustments. GII has operations around the world and will expand our product offerings in the industrial fan market. The acquisition of GII is subject to certain regulatory and other approvals and is currently expected to close in the fourth quarter of 2013.

Critical Accounting Policies

The methods, estimates and judgments that we use in applying our critical accounting policies have a significant impact on our results of operations and financial position. We evaluate our estimates and judgments on an ongoing basis. Our estimates are based upon our historical experience, our evaluation of business and macroeconomic trends and information from other outside sources, as appropriate. Our experience and assumptions form the basis for our judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may vary from what our management anticipates and different assumptions or estimates about the future could have a material impact on our results of operations and financial position. There have been no significant additions to the methods, estimates and judgments included in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in our 2012 Form 10-K.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk from changes in short-term interest rates, foreign currency exchange rates and commodity prices that could impact our results of operations and financial condition. We address our exposure to these risks through our normal operating and financing activities.


31

Interest Rate Risk

We are subject to exposure from changes in short-term interest rates related to interest payments on our borrowing arrangements. Under the Deutsche Bank Credit Agreement, all of our borrowings as of September 27, 2013 are variable rate facilities based on LIBOR or EURIBOR. In order to mitigate our interest rate risk, we periodically enter into interest rate swap or collar agreements. A hypothetical increase in the interest rate of 1.00% during the third quarter and nine months ended September 27, 2013 would have increased Interest expense by approximately $4.2 million and $12.5 million, respectively.

Exchange Rate Risk

We have manufacturing sites throughout the world and sell our products globally. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. dollar and against the currencies of other countries in which we manufacture and sell products and services. During the third quarter and nine months ended September 27, 2013, approximately 81% and 80%, respectively, of our sales were derived from operations outside the U.S. We have significant manufacturing operations in European countries that are not part of the Eurozone. Sales revenues are more highly weighted toward the Euro and U.S. dollar. We also have significant contractual obligations in U.S. dollars that are met with cash flows in other currencies as well as U.S. dollars. To better match revenue and expense as well as cash needs from contractual liabilities, we regularly enter into cross currency swaps and forward contracts.

We also face exchange rate risk from our investments in subsidiaries owned and operated in foreign countries. The euro denominated term A-3 and term A-4 facilities under the Deutsche Bank Credit Agreement (the “Term Loans A-3 and A-4”), provide a natural hedge to a portion of our European net asset position. See Note 8, “Debt” in our Notes to Condensed Consolidated Financial Statements included in this Form 10-Q for additional information regarding our debt facilities. The effect of a change in currency exchange rates on our net investment in international subsidiaries, net of the translation effect of the Company’s Term Loans A-3 and A-4, is reflected in the Accumulated other comprehensive loss component of Equity. A 10% depreciation in major currencies, relative to the U.S. dollar as of September 27, 2013 (net of the translation effect of our Term Loans A-3 and A-4) would result in a reduction in Equity of approximately $150 million.

We also face exchange rate risk from transactions with customers in countries outside the U.S. and from intercompany transactions between affiliates. Although we use the U.S. dollar as our functional currency for reporting purposes, we have manufacturing sites throughout the world, and a substantial portion of our costs are incurred and sales are generated in foreign currencies. Costs incurred and sales recorded by subsidiaries operating outside of the U.S. are translated into U.S. dollars using exchange rates effective during the respective period. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. dollar. In particular, the Company has more sales in European currencies than it has expenses in those currencies. Although a significant portion of this difference is hedged, when European currencies strengthen or weaken against the U.S. dollar, operating profits are increased or decreased, respectively.

We have generally accepted the exposure to exchange rate movements without using derivative financial instruments to manage this risk. Both positive and negative movements in currency exchange rates against the U.S. dollar will, therefore, continue to affect the reported amount of sales, profit, assets and liabilities in our Consolidated Financial Statements.

Commodity Price Risk

We are exposed to changes in the prices of raw materials used in our production processes. Commodity futures contracts are periodically used to manage such exposure. As of September 27, 2013, we had no open commodity futures contracts.

See Note 11, “Financial Instruments and Fair Value Measurements” in our Notes to Condensed Consolidated Financial Statements included in this Form 10-Q for additional information regarding our derivative instruments.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of September 27, 2013. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were

32

effective in providing reasonable assurance that the information required to be disclosed in this report on Form 10-Q has been recorded, processed, summarized and reported as of the end of the period covered by this report on Form 10-Q.
 
Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
 
Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f)) identified in connection with the evaluation required by Rule 13a-15(d) of the Exchange Act that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


33

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

Discussion of legal proceedings is incorporated by reference to Note 12, “Commitments and Contingencies,” in the Notes to Condensed Consolidated Financial Statements included in Part I. Item 1. “Financial Statements” of this Form 10-Q.

Item 1A. Risk Factors

An investment in our common stock involves a high degree of risk. There have been no material changes to the risk factors included in “Part I. Item 1A. Risk Factors” in our 2012 Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On September 12, 2013, the Company contributed 88,200 shares of newly issued Colfax Common stock to its U.S. defined benefit pension plan.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.


34

Item 6. Exhibits
Exhibit No.
Exhibit Description
 
 
3.01*
Amended and Restated Certificate of Incorporation.
 
 
3.02**
Colfax Corporation Amended and Restated Bylaws.
 
 
3.03***
Amended and Restated Certificate of Designations of Series A Perpetual Convertible Preferred Stock.
 
 
31.01
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
31.02
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
32.01
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
32.02
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
101.INS****
XBRL Instance Document
 
 
101.SCH****
XBRL Taxonomy Extension Schema Document
 
 
101.CAL****
XBRL Extension Calculation Linkbase Document
 
 
101.DEF****
XBRL Taxonomy Extension Definition Linkbase Document
 
 
101.LAB****
XBRL Taxonomy Extension Label Linkbase Document
 
 
101.PRE****
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
* Incorporated by reference to Exhibit 3.01 to Colfax Corporation’s Form 8-K (File No. 001-34045) as filed with the SEC on January 30, 2012.

** Incorporated by reference to Exhibit 3.2 to Colfax Corporation’s Form 8-K (File No. 001-34045) as filed with the SEC on May 8, 2008.


*** Incorporated by reference to Exhibit 3.03 to Colfax Corporation’s Form 10-Q (File No. 001-34045) as filed with the SEC on April 25, 2013.

**** In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


35

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Registrant:     Colfax Corporation

By:

/s/ STEVEN E. SIMMS     President and Chief Executive Officer
Steven E. Simms        (Principal Executive Officer)            October 24, 2013

/s/ C. SCOTT BRANNAN     Senior Vice President, Finance and
C. Scott Brannan        Chief Financial Officer
(Principal Financial and Accounting Officer)        October 24, 2013




36